DYN
Dyne Therapeutics, Inc. · Healthcare
Director Jason P Rhodes sold $5.6M of Dyne Therapeutics, Inc.
Sold$5,646,497
$21.09Price
267,760Shares
−20%Stake
What DYN did after the filing
- The stock from Fri, Jun 26 open, $20.96
- +26.4%
- S&P 500, same days
- +6.0%
Measured over 30 trading days, to the Aug 10 close.
Traded Tue, Jun 23. Filed Fri, Jun 26, 8:40 AM ET, before the open. Returns use the Jun 26 open and the Aug 10 close. Not investment advice.